Get Premium to unlock powerful stock data

Vanguard Health Care Fund Buys Insulet Corp, Diasorin SpA, Masimo Corp, Sells Abbott Laboratories, Universal Health Services Inc, Acceleron Pharma Inc

Author's Avatar
insider
Nov 02, 2021
Article's Main Image
Investment company Vanguard Health Care Fund (Current Portfolio) buys Insulet Corp, Diasorin SpA, Masimo Corp, Asahi Intecc Co, Exact Sciences Corp, sells Abbott Laboratories, Universal Health Services Inc, Acceleron Pharma Inc, BeiGene, Sana Biotechnology Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Vanguard Health Care Fund . As of 2021Q3, Vanguard Health Care Fund owns 110 stocks with a total value of $49.1 billion. These are the details of the buys and sells.

For the details of

Vanguard Health Care Fund 's stock buys and sells, go to https://www.gurufocus.com/guru/vanguard+health+care+fund/current-portfolio/portfolio

These are the top 5 holdings of Vanguard Health Care Fund
  1. UnitedHealth Group Inc (UNH) - 7,180,268 shares, 5.71% of the total portfolio.
  2. AstraZeneca PLC (AZN) - 22,974,215 shares, 5.64% of the total portfolio. Shares reduced by 1.84%
  3. Pfizer Inc (PFE) - 61,301,916 shares, 5.37% of the total portfolio. Shares reduced by 12.73%
  4. Eli Lilly and Co (LLY) - 10,305,313 shares, 4.85% of the total portfolio. Shares reduced by 1.88%
  5. Novartis AG (NOVN) - 21,001,073 shares, 3.51% of the total portfolio.
New Purchase: Diasorin SpA (DIA)

Vanguard Health Care Fund initiated holding in Diasorin SpA. The purchase prices were between $156.6 and $206.2, with an estimated average price of $181.66. The stock is now traded at around $197.150000. The impact to a portfolio due to this purchase was 0.12%. The holding were 270,468 shares as of 2021-09-30.

New Purchase: Asahi Intecc Co Ltd (7747)

Vanguard Health Care Fund initiated holding in Asahi Intecc Co Ltd. The purchase prices were between $2649 and $3360, with an estimated average price of $3062.62. The stock is now traded at around $2994.000000. The impact to a portfolio due to this purchase was 0.11%. The holding were 2,023,500 shares as of 2021-09-30.

New Purchase: Masimo Corp (MASI)

Vanguard Health Care Fund initiated holding in Masimo Corp. The purchase prices were between $249 and $285.24, with an estimated average price of $270.95. The stock is now traded at around $290.330000. The impact to a portfolio due to this purchase was 0.11%. The holding were 198,716 shares as of 2021-09-30.

New Purchase: NanoString Technologies Inc (NSTG)

Vanguard Health Care Fund initiated holding in NanoString Technologies Inc. The purchase prices were between $46.1 and $63.75, with an estimated average price of $57.65. The stock is now traded at around $48.020000. The impact to a portfolio due to this purchase was 0.09%. The holding were 964,373 shares as of 2021-09-30.

New Purchase: Glaukos Corp (GKOS)

Vanguard Health Care Fund initiated holding in Glaukos Corp. The purchase prices were between $47.43 and $84.23, with an estimated average price of $55.92. The stock is now traded at around $45.010000. The impact to a portfolio due to this purchase was 0.09%. The holding were 934,746 shares as of 2021-09-30.

New Purchase: Tecan Group Ltd (TECN)

Vanguard Health Care Fund initiated holding in Tecan Group Ltd. The purchase prices were between $465 and $594.5, with an estimated average price of $532.85. The stock is now traded at around $571.500000. The impact to a portfolio due to this purchase was 0.08%. The holding were 70,000 shares as of 2021-09-30.

Added: Insulet Corp (PODD)

Vanguard Health Care Fund added to a holding in Insulet Corp by 31.57%. The purchase prices were between $260.36 and $307.27, with an estimated average price of $285.43. The stock is now traded at around $309.350000. The impact to a portfolio due to this purchase was 0.16%. The holding were 1,180,704 shares as of 2021-09-30.

Added: Exact Sciences Corp (EXAS)

Vanguard Health Care Fund added to a holding in Exact Sciences Corp by 59.40%. The purchase prices were between $90.24 and $124.05, with an estimated average price of $105.88. The stock is now traded at around $96.530000. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,452,458 shares as of 2021-09-30.

Added: Agilon Health Inc (AGL)

Vanguard Health Care Fund added to a holding in Agilon Health Inc by 81.93%. The purchase prices were between $26.15 and $38.72, with an estimated average price of $34.27. The stock is now traded at around $24.755000. The impact to a portfolio due to this purchase was 0.09%. The holding were 3,939,367 shares as of 2021-09-30.

Added: Apellis Pharmaceuticals Inc (APLS)

Vanguard Health Care Fund added to a holding in Apellis Pharmaceuticals Inc by 168.22%. The purchase prices were between $31.4 and $69.84, with an estimated average price of $56.51. The stock is now traded at around $32.270000. The impact to a portfolio due to this purchase was 0.09%. The holding were 2,257,153 shares as of 2021-09-30.

Added: Oak Street Health Inc (OSH)

Vanguard Health Care Fund added to a holding in Oak Street Health Inc by 50.64%. The purchase prices were between $42.53 and $64.54, with an estimated average price of $53.75. The stock is now traded at around $45.740000. The impact to a portfolio due to this purchase was 0.09%. The holding were 2,978,154 shares as of 2021-09-30.

Added: NeoGenomics Inc (NEO)

Vanguard Health Care Fund added to a holding in NeoGenomics Inc by 54.05%. The purchase prices were between $41.66 and $52.52, with an estimated average price of $46.33. The stock is now traded at around $46.800000. The impact to a portfolio due to this purchase was 0.08%. The holding were 2,464,677 shares as of 2021-09-30.

Sold Out: Acceleron Pharma Inc (XLRN)

Vanguard Health Care Fund sold out a holding in Acceleron Pharma Inc. The sale prices were between $115.25 and $182.78, with an estimated average price of $130.74.

Sold Out: Sana Biotechnology Inc (SANA)

Vanguard Health Care Fund sold out a holding in Sana Biotechnology Inc. The sale prices were between $16.29 and $25.88, with an estimated average price of $21.02.

Sold Out: Angelalign Technology Inc (06699)

Vanguard Health Care Fund sold out a holding in Angelalign Technology Inc. The sale prices were between $313.6 and $461, with an estimated average price of $387.2.

Sold Out: Shanghai Henlius Biotech Inc (02696)

Vanguard Health Care Fund sold out a holding in Shanghai Henlius Biotech Inc. The sale prices were between $24 and $38.25, with an estimated average price of $30.42.



Here is the complete portfolio of Vanguard Health Care Fund. Also check out:

1. Vanguard Health Care Fund's Undervalued Stocks
2. Vanguard Health Care Fund's Top Growth Companies, and
3. Vanguard Health Care Fund's High Yield stocks
4. Stocks that Vanguard Health Care Fund keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus